AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 182 filers reported holding AXSOME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $25,288,000 | +9.6% | 610,970 | 0.0% | 0.14% | +29.5% |
| Q4 2021 | $23,082,000 | +29.9% | 610,970 | +13.3% | 0.11% | +43.6% |
| Q3 2021 | $17,767,000 | -51.1% | 539,057 | 0.0% | 0.08% | -51.2% |
| Q2 2021 | $36,365,000 | +2.2% | 539,057 | -14.2% | 0.16% | +3.9% |
| Q1 2021 | $35,581,000 | -43.9% | 628,414 | -19.3% | 0.15% | -35.6% |
| Q4 2020 | $63,452,000 | -7.2% | 778,834 | -18.9% | 0.24% | -12.5% |
| Q3 2020 | $68,383,000 | -17.7% | 959,757 | -5.0% | 0.27% | -25.4% |
| Q2 2020 | $83,083,000 | +58.7% | 1,009,757 | +13.5% | 0.37% | +13.7% |
| Q1 2020 | $52,344,000 | -39.0% | 889,757 | +7.2% | 0.32% | -29.4% |
| Q4 2019 | $85,764,000 | +448.7% | 829,757 | +7.4% | 0.46% | +330.2% |
| Q3 2019 | $15,631,000 | -21.4% | 772,286 | 0.0% | 0.11% | -21.5% |
| Q2 2019 | $19,886,000 | +16.5% | 772,286 | -35.6% | 0.14% | +23.9% |
| Q1 2019 | $17,076,000 | – | 1,200,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,009,799 | $82,268,000 | 41.24% |
| Fairmount Funds Management LLC | 220,098 | $17,931,000 | 6.41% |
| WMS Partners, LLC | 250,000 | $20,368,000 | 3.51% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,064,158 | $168,167,000 | 3.06% |
| MORGAN JESS S & CO INC | 44,468 | $3,623,000 | 2.88% |
| RTW INVESTMENTS, LP | 1,672,416 | $136,252,000 | 2.29% |
| RA Capital Management | 1,655,447 | $134,869,000 | 1.88% |
| Nicholas Investment Partners, LP | 207,452 | $16,901,000 | 1.30% |
| Affinity Asset Advisors, LLC | 25,000 | $2,037,000 | 1.08% |
| Parkman Healthcare Partners LLC | 30,758 | $2,506,000 | 0.64% |